Author:
Choi Dong-Young,Lee Young-Jung,Lee Sun Young,Lee Yoot Mo,Lee Hyun Hee,Choi Im Seop,Oh Ki-Wan,Han Sang Bae,Nam Sang-Yoon,Hong Jin Tae
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference35 articles.
1. Ahmed, T. and Gilani, A. H., Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease. Pharmacol. Biochem. Behav., 91, 554–559 (2009).
2. Auld, D. S., Kornecook, T. J., Bastianetto, S., and Quirion, R., Alzheimer’s disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol., 68, 209–245 (2002).
3. Bailey, J. A., Ray, B., Greig, N. H., and Lahiri, D. K., Rivastigmine lowers Abeta and increases sAPPalpha levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons. PLoS One, 6, e21954 (2011).
4. Beatty, W. W., Butters, N., and Janowsky, D. S., Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav. Neural Biol., 45, 196–211 (1986).
5. Choi, D. Y., Lee, J. W., Lin, G., Lee, Y. J., Ban, J. O., Lee, Y. H., Choi, I. S., Han, S. B., Jung, J. K., Lee, W. S., Lee, S. H., Kwon, B. M., Oh, K. W., and Hong, J. T., Obovatol improves cognitive functions in animal models for Alzheimer’s disease. J. Neurochem., 120, 1048–1059 (2012a).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献